Dr. BHOSALE SUMIT
Junior Resident-1
Dept. of Orthopedics
Dr . PRAMOD SARKELWAD DR.DEEPAK AGRAWAL
ASSO. Professor and HOU PROF. and HOD
Dept. of Orthopaedics Dept. Of Orthopaedics
DUPMC & H DUPMC & H
FACTORS AFFECTING FRACTURE
HEALING AND REMODELING
Aspiration for ideal fracture healing necessitates a comprehensive
knowledge and understanding of all the factors that directly or
indirectly influence the healing process. The main pillars of fracture
healing are a good biological environment with adequate blood supply
and a good mechanical environment with adequate stability.
The AO has set four principles for ideal fracture healing. This includes
fracture reduction to restore the anatomy, fracture fixation to achieve
absolute or relative stability, preservation of the blood supply to the
bone and surrounding soft tissues, and early and safe mobilization.
The list of factors that affect fracture healing is exhaustive; however,
it can broadly be categorized into local and systemic categories.
Local Factors
•The blood supply and the biological environment are the most important local factors affecting
the fracture healing process. Immediately after the fracture, the blood vessels in the surrounding
area get disrupted with resultant low blood. This improves over the next few hours to days after the
fracture and reaches its highest at two weeks, then declines back to normal between 3 to 5 months.
Reduced blood supply to the fracture site can lead to delayed union or non-union. Bone blood
supply should also be considered in the operative treatment of fractures and the used prosthesis. For
example, reaming for intramedullary nailing would compromise 50% to 80% of the endosteal
circulation. Also, canal tight-fitting nails compromise the endosteal blood supply compared to
looser-fitting nails, which allow better endosteal reperfusion.
•Fracture Characteristics and the mechanical environment: Excessive movement and
malalignment. Extensive soft tissue damage and soft tissues caught within the fracture site can lead
to delayed union or non-union, as well as the amount of bone comminution and loss. Additionally,
specific fracture patterns have more probabilities of developing non-union or delayed union, such
as segmental fractures or fractures with butterfly fragments.
•Infection: can significantly compromise the healing process with a consequent non-union or
delayed unions.
Systemic Factors
•Advanced age: elderly have a lower capacity for fracture healing when compared to their
younger population. Aging influences the inflammatory response during fracture healing.
With aging, there is a weakness in the immune response and increased systemic pro-
inflammatory status.
•Obesity: In animal studies, lower levels of FGF and TGF-β, and higher levels of TNF-α,
were reported more in obese mice and contributed to delayed fracture healing.
•Anemia
•Endocrine conditions: diabetes mellitus affects the fracture healing process in multiple
aspects; fracture callus would have low cellular content with resultant weak callus.
Endochondral ossification is delayed, and fracture healing is generally prolonged compared to
the general population. Menopause and parathyroid problems also compromise the fracture-
healing process.
•Steroid administration.
•Malnutrition: a high proportion of the patients developing delayed union or non-union were
reported to have metabolic compromise, especially of vitamin D. Calcium deficiency is
another compromising factor of the bone union. Calcium deficiency can be secondary to
gastrointestinal malabsorption or endocrinal problems such as secondary
hyperparathyroidism.
•Smoking: nicotine inhibits angiogenesis and forms weak calluses
with an overall delay in the fracture healing process.
•Medications: Certain medications can directly or indirectly affect
the fracture healing process. NSAIDs can result in delayed union
due to COX enzyme inhibition. For example, systemic
corticosteroids have been reported to increase the non-union rate of
intertrochanteric femur fracture. Conversely, long-term use of
bisphosphonates has been associated with osteoporotic fractures
such as subtrochanteric femoral insufficiency fractures. Quinolones
have been reported to be toxic to chondrocytes with the consequent
compromise of the fracture healing process.
•Dietary supplements - calcium, protein, vitamins C and D.
•Bone stimulators - which can be electrical, electromagnetic, and ultrasound. The current
effectiveness of these methods is still equivocal, and this area requires further research. There
are four principal modes of electrical stimulation; the direct current reduces osteoclast
activity and increases osteoblast activity by creating an alkaline tissue environment and
reducing oxygen concentration. In contrast, the alternating current (AC) affects collagen
synthesis and cartilage calcification. The other two types are magnetic, either pulsed
electromagnetic fields that result in the calcification of fibrocartilage or combined magnetic
fields that increase the concentrations of transforming growth factor beta and bone
morphogenic proteins. Ultrasound such as (LIPUS) low-intensity pulsed ultrasound has been
reported to augment fracture healing and increase the strength of the formed callus, with
healing rates in non-union and delayed unions approaching 80%. LIPUS improves fracture
healing by increasing chondrocytes, soft callus formation, and, consequently, earlier
endochondral ossification.
•A bone graft involves using bone to help provide a scaffold to the newly forming bone. This
graft can be from the patient's body (autograft) or a deceased donor (allograft).
 I. SYSTEMIC FACTORS OR PATIENT VARIABLES
 II.LOCAL FACTORS OR TISSUE VARIABLES
a.Factors independent of injury, treatment, or
complications
b. Factors dependent of injury or injury variables
 III. Factors depending on treatment or treatment variables
 IV. Factors associated with complications
 I. Systemic factors or patient variables
A. Age
B. Activity level including
1. Immobilization
C. Nutritional status
1. Sufficient carbohydrates and protein
2. Anaemia
3. Vitamin deficiencies: C, D, K
D. Hormonal factors
1. Growth hormone
2. Corticosteroids
3. Others (thyroid, oestrogen, androgen,
calcitonin, parathyroid hormone,
prostaglandins)
E. Diseases: Diabetes, neuropathies, Tabesdorsalis,
PVD, malignancies,
immunocomprised states(hiv& aids)
F. Drugs: NSAIDs, Steroids, statins,anticoagulants,
Antibiotics like Fluroquinolones
G. Smoking & alcohol abuse
H. Hyperoxia
I. Systemic growth factors
J. Central nervous system trauma
Changes in fracture healing caused by diabetes
Changes at the tissue level
Reduced bone formation
Reduced cartilage formation
Accelerated loss of cartilage
Reduced vascularity and reduced angiogenesis
Changes at the molecular level
Reduced expression of growth factors
Reduced expression of matrix proteins
Increased expression of proinflammatory genes
Increased expression of pro-osteoclastogenic factors
Increased expression of proapoptotic genes
II. Local factors or tissue variables
A. Factors independent of injury, treatment, or
complications
1. Type of bone
cortical or cancellous
2. Abnormal bone
a. Radiation necrosis
b. Infection
c. Tumours and other
pathological conditions
3. Denervation
B. Factors depending on injury or injury variables
1. Degree of local damage
a. Compound fracture
b. Comminution of fracture
c. segmental fractures
d. Velocity of injury
2. Extent of disruption of vascular supply to
bone, its fragments (macro vascular
osteonecrosis), or soft tissues;
3. Type and location of fracture (one or two
bones, e.g., tibia and fibula or tibia alone
4. Loss of bone
5. Soft-tissue interposition
6. Local growth factors
7. Intra articular fractures
C. Factors depending on treatment
or treatment variables
1. Extent of surgical trauma (blood supply, heat)
2. Implant-induced altered blood flow
3. Degree and kind of rigidity of internal or
external fixation and the influence of timing
4. Degree, duration, and direction of load-
induced deformation of bone and soft tissues
5. Apposition of fracture fragments (gap,
displacement, over distraction
6. Factors stimulating posttraumatic
osteogenesis (bone grafts, bone
morphogenetic protein, electrical stimulation,
surgical technique, intermittent venous stasis .
 D. Factors associated with complications
1. Infection
2. Venous stasis
3. Metal allergy
Local Regulation of Bone Healing
 Growth factors
Transforming growth factor
Bone morphogenetic proteins
Fibroblast growth factors
Platelet-derived growth factors
Insulin-like growth factors
 Cytokines
Interleukin-1,-4,-6,-11, macrophage and
granulocyte/macrophage (GM) colony-stimulating factors
(CSFs) and Tumor Necrosis Factor
 Prostaglandins/ Leukotrienes
 Hormones
 Growth factor antagonists
Specific Factor Stimulation of
Osteoblasts and Osteoclasts
 Cytokine Bone Formation Bone Resorption
 IL-1 + +++
 TNF-α + +++
 TNF-β + +++
 TGF-α -- +++
 TGF-β ++ ++
 PDGF ++ ++
 IGF-1 +++ 0
 IGF-2 +++ 0
 FGF +++ 0
Timing and Function of Growth Factors
Transforming Growth Factor
 Super-family of growth factors (~34 members)
 Acts on serine/ threonine kinase cell wall
receptors
 Promotes proliferation and differentiation of
mesenchymal precursors for osteoblasts,
osteoclasts and chondrocytes
 Stimulates both enchondral and
intramembranous bone formation
 Induces synthesis of cartilage-specific proteoglycans
and type II collagen
 Stimulates collagen synthesis by osteoblasts
Bone Morphogenetic Proteins
 These are included in the TGF-β family
 Except BMP-1
 Sixteen different BMP’s have been identified
 BMP2-7,9 are Osteoinductive
 BMP2,6, & 9 may be the most potent in osteoblastic
differentiation
 Involved in progenitor cell transformation to pre-
osteoblasts
 Work through the intracellular Smad pathway
 Follow a dose/response ratio
Bone Morphogenetic Proteins
 Induce cell differentiation
 BMP-3 (osteogenin) is an extremely potent inducer
of mesenchymal tissue differentiation into bone
 Promote endochondral ossification
 BMP-2 and BMP-7 induce endochondral bone
formation in segmental defects
 Regulate extracellular matrix production
 BMP-1 is an enzyme that cleaves the carboxy
termini of procollagens I, II and III
Clinical Use of BMP’s
 Used at doses between 10x & 1000x native levels
 rhBMP-2 used in “fresh” open fractures to enhance
healing and reduce need for secondary procedures after
unreamed IM nailing
 BMP-7 approved for use in recalcitrant nonunions in
patients for whom auto grafting is not a good option
(i.e. medically unstable, previous harvesting of all iliac
crest sites, etc.)
BMP Future Directions
 BMP-2
 Increased fusion rate in spinal fusion
 BMP-7 equally effective as ICBG in
nonunions (small series: need larger
studies)
 Must be applied locally (insert them
surgically in the fracture site) because of
rapid systemic clearance.
BMP Antagonists
 May have important role in bone formation
 Noggin
 Extra-cellular inhibitor
 Competes with BMP-2 for receptors
 BMP-13 found to limit differentiation of mesenchymal
stromal cells
 Inhibits osteogenic differentiation
Fibroblast Growth Factors
 Both acidic (FGF-1) and basic (FGF-2) forms
 Increase proliferation of chondrocytes and
osteoblasts
 Enhance callus formation
 FGF-2 stimulates angiogenesis
Platelet-Derived Growth Factor
 A dimer of the products of two genes, PDGF-A and PDGF-B
 PDGF-BB and PDGF-AB are the predominant forms found
in the circulation
 Stimulates bone cell growth
 Increases type I collagen synthesis by increasing the
number of osteoblasts
 PDGF-BB stimulates bone resorption by increasing the
number of osteoclasts
Insulin-like Growth Factor
 Two types: IGF-I and IGF-II
 Synthesized by multiple tissues
 IGF-I production in the liver is stimulated by
Growth Hormone
 Stimulates bone collagen and matrix synthesis
 Stimulates replication of osteoblasts
 Inhibits bone collagen degradation
Cytokines
 Interleukin-1,-4,-6,-11, granulocyte/macrophage (GM)
colony-stimulating factors (CSFs) and Tumor Necrosis
Factor
 Stimulate bone resorption
 IL-1 is the most potent
 IL-1 and IL-6 synthesis is decreased by estrogen
 May be mechanism for post-menopausal bone
resorption
 Peak during 1st
24 hours of fracture healing then again
during remodeling
 Regulate endochondral bone formation
Prostaglandins / Leukotrienes
 Effect on bone resorption is species dependent and their
overall effects in humans unknown
 Prostaglandins of the E series
 Stimulate osteoblastic bone formation
 Inhibit activity of isolated osteoclasts
 Leukotrienes
 Stimulate osteoblastic bone formation
 Enhance the capacity of isolated osteoclasts to form
resorption pits
Hormones
 Estrogen
 Stimulates fracture healing through receptor mediated
mechanism
 Modulates release of a specific inhibitor of IL-1
 Thyroid hormones
 Thyroxine and triiodothyronine excess stimulate
osteoclastic bone resorption
 Glucocorticoids
 Inhibit calcium absorption from the gut causing increased
PTH and therefore increased osteoclastic bone resorption
Hormones (cont.)
 Parathyroid Hormone
 Intermittent exposure stimulates
Osteoblasts
Increased bone formation
 Growth Hormone
 Mediated through IGF-1 (Somatomedin-C)
 Increases callus formation and fracture strength
Vascular Factors
 Metalloproteinases
 Degrade cartilage and bones to allow invasion of vessels
 Angiogenic factors
 Vascular-endothelial growth factors
Mediate neo-angiogenesis & endothelial-cell specific
mitogens
 Angiopoietin (1&2)
Regulate formation of larger vessels and branches
Electromagnetic Field
 Electromagnetic (EM) devices are based on Wolff’s
Law that bone responds to mechanical stress: In vitro
bone deformation produces piezoelectric currents
and streaming potentials.
 Exogenous EM fields may stimulate bone growth and
repair by the same mechanism
 Clinical efficacy very controversial
 No studies have shown PEMF to be effective in
“gap healing” or pseudarthrosis
Types of EM Devices
 Microamperes
 Direct electrical current
 Capacitively coupled electric fields
 Pulsed electromagnetic fields (PEMF)
PEMF
 Approved by the FDA for the treatment of non-unions
 Efficacy of bone stimulation appears to be frequency
dependant
 Extremely low frequency (ELF) sinusoidal electric fields in
the physiologic range are most effective (15 to 30 Hz
range)
 Specifically, PEMF signals in the 20 to 30 Hz range
(postural muscle activity) appear more effective than
those below 10 Hz (walking)
Ultrasound
 Low-intensity ultrasound is approved by the FDA for
stimulating healing of fresh fractures
 Human clinical trials show a decreased time of healing in
fresh fractures treated non-operatively
 Four level 1 studies show a decrease in healing time up to
38%
 Has also been shown to decrease the healing time in smokers
potentially reversing the ill effects of smoking
DETERMINANTS OF FRACTURE
HEALING
1.METHOD OF TREATMENT:
- Stability of the fracture site determines the
differentiation of progenitor cells and the amount of -
callus formation.
- With absolute stability, rigid fixation and low
strain environment, there is no movement(500-2000
micro strain)at the fracture site and fracture heals
with “primary fracture repair”
2.ENDOCRINE INFLUENCE AND EFFECT OF
LOCAL GROWTH FACTORS :
3. EFFECT OF AGE:
Faster in younger patients by a factor of 1.5-2 times
when compared to elderly.
Causes of delay in old age:
-Delay in onset of periosteal reaction(due to-
periosteal and its cambial layer atrophy)
-Delay in cell proliferation(due to aging effect-
on cells)
-Decreased bone formation( due to lower-
osteo-inductuve capacity of bone matrix.)
-Delayed angiogenic invasion of cartilage (due to
decreased expression of VEGF, PDGF, Hypoxia-
inducible factor-1 alpha)
4.LOCATION OF THE FRACTURE:
-Metaphyseal fractures heal faster than Diaphyseal.
-Upper limb fractures heals faster than Lower limb
fractures.
5. LOSS OF BONE:
decreases fracture healing
6. INTERPOSITION OF SOFT TISSUES:
decreases fracture healing
7. IMPLANT INDUCED ALTERED BLOOD FLOW:
decreases fracture healing process.
8. DRUGS:
Drugs disrupting bone healing are,
-Corticosteroids, Immunosuppressants, NSAIDS,
Fluoroquinolones, Tetracyclines
Rifampicin, Gentamicin, Povidone Iodine
9. SMOKING AND ALCOHOLISM:
-Nicotine decreases Osteoblast activity
-It inhibits revascularization of bone grafts
-It inhibits expression of wide range of cytokines
-Induces Osteoporosis
-Reduces estrogen effectiveness
-Counter the antioxidant property of Vit.C and E
10. CHEMICAL OR THERMAL BURNS:
Decreases fracture healing
11. ANAEMIA AND HYPOXIA:
Decreases fracture healing
12. DENERVATION AND NEUROPATHIES:
Decreases fracture healing
13. INFECTIONS:
Delays healing
14. VENOUS STASIS:
Delays healing
15. METAL ALLERGY:
Delays healing
16. EFFECTS OF RADIATION:
-Causes long term suppressive effect on Haversian
system by reducing vascularity and cellularity.
-Post operative Radiations reduces bone graft
incorporation and should be delayed for 3 weeks.
-It may lead to Osteo-radionecrosis, Fractures, Bone
growth changes, Radiation induced Cancers
SOME FACTS TO NOTE
 Fracture repair and consolidation are inversely proportional to the amount of
mobility at fracture site.
 Compression at fracture;
-physiological compression stimulate bone
formation
-compression is useful for spongy bone while its
harmful for diaphyseal bones
METHODS TO ENHANCE FRACTURE HEALING
 ELECTRICAL STIMULATION;
-Direct current
-Inductive coupling
-Capacitive coupling
 EXTRA CORPOREAL SHOCK WAVE THERAPY
 MECHANICAL STIMULATION
 BIOLOGICAL METHODS
-Bone morphogenic proteins
-Prostacyclins
-Platelet concentrate and Bone marrow injections
-Parathyroid hormone
-Ultra concentrate of centrifuged blood
-Anabolic supplementations and minerals
-Bone grafts and substitutes
FACTORS INFLUENCING/AFFECTING
FRACTURE HEALING
 These factors can be subdivided into systemic and local factors.
 Systemic factors present at the time of injury with exception of trauma to the
CNS.
 Local factors subdivided according to their nature such as mechanical ,
chemical ,physical, or environmental. Such classification has little clinical
importance.
SYSTEMIC FACTORS
A. Age
B. Activity level including---
1. General immobilization
2. space flight
C. Nutritional status
D. Hormonal factors
1.GH
2.Corticosteroids(microvascular AVN)
3. others- thyroid, estrogen , androgen,
calcitonin, PTH,PG
E. Diseases:- anemia, neuropathies,tabes
F. Vitamin defcncy: A,D,E,K
G. Drugs : NSAIDs, anticoagulants ,CCB, sodium fluride, tetracycline.
H. Nicotine, alcohol
I. Hyperoxia
J. Systemic growth factors
K. Environmental temperature
L. CNS trauma
LOCAL FACTORS
A. Factors independent of injury, treatment, or complications
1. Type of bone
2. Abnormal bone
-- radiation necrosis
--- infection
--- tumours and other pathologic conditions.
3. Denervation
B. Factors depending on injury
1. Degree of local damage
a.compound #
b. communition of #
c. velocity of injury
d. low circulation levels of vit.K
2. Extent of disruption of vascular supply to bone, it,s fragments, soft tissue or
severity of injury.
3. Type and location of fracture( one /2 bones ie tibia and fibula or tibia
alone.
4. Loss of bone
5. soft tissue interposition
6. Local growth factors.
C. Factors depending on treatment___
1. Extent of surgical trauma( bld supply, heat)
2. Implant induced altered bld flow
3. Degree and kind of rigidity of external/internal
fixation and influence of timing.
4. Degree, duration and direction of load- induced
deformation of bone and soft tissue
5. Extent of contact b/w fragments
6. Factors stimulating post traumatic osteogenesis
----- bone graft, BMPs, electrical stimulation ,surgical
technique ,intermittent venous stasis.
D. Factors associated with complications
1. infection
2. venous stasis
3. metal allergy
VARIABLES THAT INFLUENCE FRACTURE
HEALING
 Cruess and Buck Walter have devided the varibles into 4 Groups
1. INJURY VARIABLES
2. PATIENT VARIABLES
3. TISSUE VARIBLES
4. TREATMENT VARIABLES
1. INJURY VARIABLE
A) Open #s---- causes soft tissue destruction and disturbe blood suply prevent
haematoma fornation and delayed repair
B) Severity of injury----- severe injury lead to extensive soft tissue damage
and bone communition with displacement ,leading to retardation of fracture
healing.
C. Intra-articular #s ----
synovial fluid hinders the fracture healing as it contains collagenases which
degrade the matrix of initial # callus. So intra-articular #s require
reconstruction of joint, stable fixation of fragments and early mobilisation.
D) Soft tissue interposition----
compromise # healing
E) Segmental fracture------ of long bone impairs the intramedullary blood suply
of middle fragment resulting in delayed union/non union.
F) Damage to blood supply----
lead to delay/ prevent # healing.
PATIENT VARIBLES
1. Age:- infants and childrn have rapid rate of healing where as healing
declines significantly with age advances.
2. Nutrition :- poor nutritional status decreases synthesis of large volumes of
collagens, polyglycans and other matrix macromolecules, hence affect
fracture healing and can lead to mortality.
3. Systemic hormones:-- corticosteroids, NSAIDs , anticoagulants inhibit fracture
healing. Where as GH, TH,insulin,and anabolic steroids enhance fracture
healing.
4. Nicotine :-- cigarette smoking inhibit # healing by inhibiting vascularisation of
cancellous bone graft.
TISSUE VARIABLES
1. Form of bone ( cancellous/ cortical):
cancellous bone healing rapid because of larger surface area per unit
volume,and rich blood supply.
2. Bone necrosis :-- leads to decreased bone healing.
3. Bone diseases :- osteoporosis, osteomalacia, primary malignant tumors,
osteogenesis imperfecta etc all cause pathological # and delay in healing
process.
4. Infection :- slow down / prevents healing. Infection will cause necrosis of
normal tissue, edema and thrombosis of blood vessels, threby retarding or
prevent healing.
TREATMENT VARIABLES
1. Apposition of fracture fragments :- Decreasing the # gap decreases volume
of repair tissue needed to heal a fracture. Anatomical reduction causes
rapid healing as compared to displaced fragments.
2. Loading and micromotion:-- Loading a # site stimulate bone formation while
decreased loading slows fracture healing. Immediate controlled loading and
limb movement, including induced micromotion at long fracture sites,
promotes fracture healing but too much movement cause nonunion.
3. Stabilization of fracture :- will prevent repeated disruption of repair tissue
and speed up the fracture callus.
4. Rigid fixation :-- Plate like LC-DCP leads to primary union of fracture, stable
fixation allows early mobilization of joints and hence prevents stiffness.
5. Bone grafting :-- It is osteo inductive as well as osteoconductive. BMP stimulates healing.
Autograft and allograft of cancellous , cortical or cortico-cancellous bone are used to
stimulate # healing and replace lost bone.
6. Ultrasound:- low intensity pulsed USG accelerate # healing. It increases the concentration
of intracellular calcium in fracture callus chondrocytes.
7 . Demineralized mone marrow :--- The factors in bone marrow stimulate bone formation,
by migration of undifferentiated mesenchymal cells to the implanted matrix and
differentiation into chondrocytes.
Electrical and electromagnetic stimulation
The fibrous union can be converted into a fibrocartilage which then
undergoes enchondral ossification by using cathode electrodes,each
delivering an optimal osteogenic current of 20micro.amp
At least 3 electrical and electromagnetic methodes are available.
1. Invasive
2. Semi-invasive
3. Non-invasive
Invasive method
 A self powered, self contained and totally implantable electrical stimulation
is used.
 Union is achieved in more than 85% 0s cases within 12-36 weeks.
Semi-invasive method
 Consists of insertion of cathodes percutaneously into the nonunion site and
continous application of small amount of direct current. Early osteogenesis
can be detected in 12 weeks.
Non-invasive method
 Weak electric currents are induced by pulsating elctromagnetic fields.
 radiograph made after 4-6 wks interval shows evidence of healing.
REFERENCES
CAMPBELL’S OPERATIVE ORTHOPEDICS
ROCKWOOD AND GREEN
ESSENTIAL ORTHOPEDICS-VARSHNEY
THANK YOU

factors affecting fracture healing .pptx

  • 1.
    Dr. BHOSALE SUMIT JuniorResident-1 Dept. of Orthopedics Dr . PRAMOD SARKELWAD DR.DEEPAK AGRAWAL ASSO. Professor and HOU PROF. and HOD Dept. of Orthopaedics Dept. Of Orthopaedics DUPMC & H DUPMC & H
  • 2.
  • 3.
    Aspiration for idealfracture healing necessitates a comprehensive knowledge and understanding of all the factors that directly or indirectly influence the healing process. The main pillars of fracture healing are a good biological environment with adequate blood supply and a good mechanical environment with adequate stability. The AO has set four principles for ideal fracture healing. This includes fracture reduction to restore the anatomy, fracture fixation to achieve absolute or relative stability, preservation of the blood supply to the bone and surrounding soft tissues, and early and safe mobilization. The list of factors that affect fracture healing is exhaustive; however, it can broadly be categorized into local and systemic categories.
  • 4.
    Local Factors •The bloodsupply and the biological environment are the most important local factors affecting the fracture healing process. Immediately after the fracture, the blood vessels in the surrounding area get disrupted with resultant low blood. This improves over the next few hours to days after the fracture and reaches its highest at two weeks, then declines back to normal between 3 to 5 months. Reduced blood supply to the fracture site can lead to delayed union or non-union. Bone blood supply should also be considered in the operative treatment of fractures and the used prosthesis. For example, reaming for intramedullary nailing would compromise 50% to 80% of the endosteal circulation. Also, canal tight-fitting nails compromise the endosteal blood supply compared to looser-fitting nails, which allow better endosteal reperfusion. •Fracture Characteristics and the mechanical environment: Excessive movement and malalignment. Extensive soft tissue damage and soft tissues caught within the fracture site can lead to delayed union or non-union, as well as the amount of bone comminution and loss. Additionally, specific fracture patterns have more probabilities of developing non-union or delayed union, such as segmental fractures or fractures with butterfly fragments. •Infection: can significantly compromise the healing process with a consequent non-union or delayed unions.
  • 5.
    Systemic Factors •Advanced age:elderly have a lower capacity for fracture healing when compared to their younger population. Aging influences the inflammatory response during fracture healing. With aging, there is a weakness in the immune response and increased systemic pro- inflammatory status. •Obesity: In animal studies, lower levels of FGF and TGF-β, and higher levels of TNF-α, were reported more in obese mice and contributed to delayed fracture healing. •Anemia •Endocrine conditions: diabetes mellitus affects the fracture healing process in multiple aspects; fracture callus would have low cellular content with resultant weak callus. Endochondral ossification is delayed, and fracture healing is generally prolonged compared to the general population. Menopause and parathyroid problems also compromise the fracture- healing process. •Steroid administration. •Malnutrition: a high proportion of the patients developing delayed union or non-union were reported to have metabolic compromise, especially of vitamin D. Calcium deficiency is another compromising factor of the bone union. Calcium deficiency can be secondary to gastrointestinal malabsorption or endocrinal problems such as secondary hyperparathyroidism.
  • 6.
    •Smoking: nicotine inhibitsangiogenesis and forms weak calluses with an overall delay in the fracture healing process. •Medications: Certain medications can directly or indirectly affect the fracture healing process. NSAIDs can result in delayed union due to COX enzyme inhibition. For example, systemic corticosteroids have been reported to increase the non-union rate of intertrochanteric femur fracture. Conversely, long-term use of bisphosphonates has been associated with osteoporotic fractures such as subtrochanteric femoral insufficiency fractures. Quinolones have been reported to be toxic to chondrocytes with the consequent compromise of the fracture healing process.
  • 7.
    •Dietary supplements -calcium, protein, vitamins C and D. •Bone stimulators - which can be electrical, electromagnetic, and ultrasound. The current effectiveness of these methods is still equivocal, and this area requires further research. There are four principal modes of electrical stimulation; the direct current reduces osteoclast activity and increases osteoblast activity by creating an alkaline tissue environment and reducing oxygen concentration. In contrast, the alternating current (AC) affects collagen synthesis and cartilage calcification. The other two types are magnetic, either pulsed electromagnetic fields that result in the calcification of fibrocartilage or combined magnetic fields that increase the concentrations of transforming growth factor beta and bone morphogenic proteins. Ultrasound such as (LIPUS) low-intensity pulsed ultrasound has been reported to augment fracture healing and increase the strength of the formed callus, with healing rates in non-union and delayed unions approaching 80%. LIPUS improves fracture healing by increasing chondrocytes, soft callus formation, and, consequently, earlier endochondral ossification. •A bone graft involves using bone to help provide a scaffold to the newly forming bone. This graft can be from the patient's body (autograft) or a deceased donor (allograft).
  • 8.
     I. SYSTEMICFACTORS OR PATIENT VARIABLES  II.LOCAL FACTORS OR TISSUE VARIABLES a.Factors independent of injury, treatment, or complications b. Factors dependent of injury or injury variables  III. Factors depending on treatment or treatment variables  IV. Factors associated with complications
  • 9.
     I. Systemicfactors or patient variables A. Age B. Activity level including 1. Immobilization C. Nutritional status 1. Sufficient carbohydrates and protein 2. Anaemia 3. Vitamin deficiencies: C, D, K D. Hormonal factors 1. Growth hormone 2. Corticosteroids 3. Others (thyroid, oestrogen, androgen, calcitonin, parathyroid hormone, prostaglandins)
  • 10.
    E. Diseases: Diabetes,neuropathies, Tabesdorsalis, PVD, malignancies, immunocomprised states(hiv& aids) F. Drugs: NSAIDs, Steroids, statins,anticoagulants, Antibiotics like Fluroquinolones G. Smoking & alcohol abuse H. Hyperoxia I. Systemic growth factors J. Central nervous system trauma
  • 11.
    Changes in fracturehealing caused by diabetes Changes at the tissue level Reduced bone formation Reduced cartilage formation Accelerated loss of cartilage Reduced vascularity and reduced angiogenesis Changes at the molecular level Reduced expression of growth factors Reduced expression of matrix proteins Increased expression of proinflammatory genes Increased expression of pro-osteoclastogenic factors Increased expression of proapoptotic genes
  • 13.
    II. Local factorsor tissue variables A. Factors independent of injury, treatment, or complications 1. Type of bone cortical or cancellous 2. Abnormal bone a. Radiation necrosis b. Infection c. Tumours and other pathological conditions 3. Denervation
  • 14.
    B. Factors dependingon injury or injury variables 1. Degree of local damage a. Compound fracture b. Comminution of fracture c. segmental fractures d. Velocity of injury 2. Extent of disruption of vascular supply to bone, its fragments (macro vascular osteonecrosis), or soft tissues; 3. Type and location of fracture (one or two bones, e.g., tibia and fibula or tibia alone 4. Loss of bone 5. Soft-tissue interposition 6. Local growth factors 7. Intra articular fractures
  • 15.
    C. Factors dependingon treatment or treatment variables 1. Extent of surgical trauma (blood supply, heat) 2. Implant-induced altered blood flow 3. Degree and kind of rigidity of internal or external fixation and the influence of timing 4. Degree, duration, and direction of load- induced deformation of bone and soft tissues 5. Apposition of fracture fragments (gap, displacement, over distraction 6. Factors stimulating posttraumatic osteogenesis (bone grafts, bone morphogenetic protein, electrical stimulation, surgical technique, intermittent venous stasis .
  • 16.
     D. Factorsassociated with complications 1. Infection 2. Venous stasis 3. Metal allergy
  • 17.
    Local Regulation ofBone Healing  Growth factors Transforming growth factor Bone morphogenetic proteins Fibroblast growth factors Platelet-derived growth factors Insulin-like growth factors  Cytokines Interleukin-1,-4,-6,-11, macrophage and granulocyte/macrophage (GM) colony-stimulating factors (CSFs) and Tumor Necrosis Factor  Prostaglandins/ Leukotrienes  Hormones  Growth factor antagonists
  • 18.
    Specific Factor Stimulationof Osteoblasts and Osteoclasts  Cytokine Bone Formation Bone Resorption  IL-1 + +++  TNF-α + +++  TNF-β + +++  TGF-α -- +++  TGF-β ++ ++  PDGF ++ ++  IGF-1 +++ 0  IGF-2 +++ 0  FGF +++ 0
  • 19.
    Timing and Functionof Growth Factors
  • 20.
    Transforming Growth Factor Super-family of growth factors (~34 members)  Acts on serine/ threonine kinase cell wall receptors  Promotes proliferation and differentiation of mesenchymal precursors for osteoblasts, osteoclasts and chondrocytes  Stimulates both enchondral and intramembranous bone formation  Induces synthesis of cartilage-specific proteoglycans and type II collagen  Stimulates collagen synthesis by osteoblasts
  • 21.
    Bone Morphogenetic Proteins These are included in the TGF-β family  Except BMP-1  Sixteen different BMP’s have been identified  BMP2-7,9 are Osteoinductive  BMP2,6, & 9 may be the most potent in osteoblastic differentiation  Involved in progenitor cell transformation to pre- osteoblasts  Work through the intracellular Smad pathway  Follow a dose/response ratio
  • 22.
    Bone Morphogenetic Proteins Induce cell differentiation  BMP-3 (osteogenin) is an extremely potent inducer of mesenchymal tissue differentiation into bone  Promote endochondral ossification  BMP-2 and BMP-7 induce endochondral bone formation in segmental defects  Regulate extracellular matrix production  BMP-1 is an enzyme that cleaves the carboxy termini of procollagens I, II and III
  • 23.
    Clinical Use ofBMP’s  Used at doses between 10x & 1000x native levels  rhBMP-2 used in “fresh” open fractures to enhance healing and reduce need for secondary procedures after unreamed IM nailing  BMP-7 approved for use in recalcitrant nonunions in patients for whom auto grafting is not a good option (i.e. medically unstable, previous harvesting of all iliac crest sites, etc.)
  • 24.
    BMP Future Directions BMP-2  Increased fusion rate in spinal fusion  BMP-7 equally effective as ICBG in nonunions (small series: need larger studies)  Must be applied locally (insert them surgically in the fracture site) because of rapid systemic clearance.
  • 25.
    BMP Antagonists  Mayhave important role in bone formation  Noggin  Extra-cellular inhibitor  Competes with BMP-2 for receptors  BMP-13 found to limit differentiation of mesenchymal stromal cells  Inhibits osteogenic differentiation
  • 26.
    Fibroblast Growth Factors Both acidic (FGF-1) and basic (FGF-2) forms  Increase proliferation of chondrocytes and osteoblasts  Enhance callus formation  FGF-2 stimulates angiogenesis
  • 27.
    Platelet-Derived Growth Factor A dimer of the products of two genes, PDGF-A and PDGF-B  PDGF-BB and PDGF-AB are the predominant forms found in the circulation  Stimulates bone cell growth  Increases type I collagen synthesis by increasing the number of osteoblasts  PDGF-BB stimulates bone resorption by increasing the number of osteoclasts
  • 28.
    Insulin-like Growth Factor Two types: IGF-I and IGF-II  Synthesized by multiple tissues  IGF-I production in the liver is stimulated by Growth Hormone  Stimulates bone collagen and matrix synthesis  Stimulates replication of osteoblasts  Inhibits bone collagen degradation
  • 29.
    Cytokines  Interleukin-1,-4,-6,-11, granulocyte/macrophage(GM) colony-stimulating factors (CSFs) and Tumor Necrosis Factor  Stimulate bone resorption  IL-1 is the most potent  IL-1 and IL-6 synthesis is decreased by estrogen  May be mechanism for post-menopausal bone resorption  Peak during 1st 24 hours of fracture healing then again during remodeling  Regulate endochondral bone formation
  • 30.
    Prostaglandins / Leukotrienes Effect on bone resorption is species dependent and their overall effects in humans unknown  Prostaglandins of the E series  Stimulate osteoblastic bone formation  Inhibit activity of isolated osteoclasts  Leukotrienes  Stimulate osteoblastic bone formation  Enhance the capacity of isolated osteoclasts to form resorption pits
  • 31.
    Hormones  Estrogen  Stimulatesfracture healing through receptor mediated mechanism  Modulates release of a specific inhibitor of IL-1  Thyroid hormones  Thyroxine and triiodothyronine excess stimulate osteoclastic bone resorption  Glucocorticoids  Inhibit calcium absorption from the gut causing increased PTH and therefore increased osteoclastic bone resorption
  • 32.
    Hormones (cont.)  ParathyroidHormone  Intermittent exposure stimulates Osteoblasts Increased bone formation  Growth Hormone  Mediated through IGF-1 (Somatomedin-C)  Increases callus formation and fracture strength
  • 33.
    Vascular Factors  Metalloproteinases Degrade cartilage and bones to allow invasion of vessels  Angiogenic factors  Vascular-endothelial growth factors Mediate neo-angiogenesis & endothelial-cell specific mitogens  Angiopoietin (1&2) Regulate formation of larger vessels and branches
  • 34.
    Electromagnetic Field  Electromagnetic(EM) devices are based on Wolff’s Law that bone responds to mechanical stress: In vitro bone deformation produces piezoelectric currents and streaming potentials.  Exogenous EM fields may stimulate bone growth and repair by the same mechanism  Clinical efficacy very controversial  No studies have shown PEMF to be effective in “gap healing” or pseudarthrosis
  • 35.
    Types of EMDevices  Microamperes  Direct electrical current  Capacitively coupled electric fields  Pulsed electromagnetic fields (PEMF)
  • 36.
    PEMF  Approved bythe FDA for the treatment of non-unions  Efficacy of bone stimulation appears to be frequency dependant  Extremely low frequency (ELF) sinusoidal electric fields in the physiologic range are most effective (15 to 30 Hz range)  Specifically, PEMF signals in the 20 to 30 Hz range (postural muscle activity) appear more effective than those below 10 Hz (walking)
  • 37.
    Ultrasound  Low-intensity ultrasoundis approved by the FDA for stimulating healing of fresh fractures  Human clinical trials show a decreased time of healing in fresh fractures treated non-operatively  Four level 1 studies show a decrease in healing time up to 38%  Has also been shown to decrease the healing time in smokers potentially reversing the ill effects of smoking
  • 38.
    DETERMINANTS OF FRACTURE HEALING 1.METHODOF TREATMENT: - Stability of the fracture site determines the differentiation of progenitor cells and the amount of - callus formation. - With absolute stability, rigid fixation and low strain environment, there is no movement(500-2000 micro strain)at the fracture site and fracture heals with “primary fracture repair”
  • 40.
    2.ENDOCRINE INFLUENCE ANDEFFECT OF LOCAL GROWTH FACTORS :
  • 41.
    3. EFFECT OFAGE: Faster in younger patients by a factor of 1.5-2 times when compared to elderly. Causes of delay in old age: -Delay in onset of periosteal reaction(due to- periosteal and its cambial layer atrophy) -Delay in cell proliferation(due to aging effect- on cells) -Decreased bone formation( due to lower- osteo-inductuve capacity of bone matrix.) -Delayed angiogenic invasion of cartilage (due to decreased expression of VEGF, PDGF, Hypoxia- inducible factor-1 alpha)
  • 42.
    4.LOCATION OF THEFRACTURE: -Metaphyseal fractures heal faster than Diaphyseal. -Upper limb fractures heals faster than Lower limb fractures.
  • 43.
    5. LOSS OFBONE: decreases fracture healing 6. INTERPOSITION OF SOFT TISSUES: decreases fracture healing 7. IMPLANT INDUCED ALTERED BLOOD FLOW: decreases fracture healing process.
  • 44.
    8. DRUGS: Drugs disruptingbone healing are, -Corticosteroids, Immunosuppressants, NSAIDS, Fluoroquinolones, Tetracyclines Rifampicin, Gentamicin, Povidone Iodine
  • 46.
    9. SMOKING ANDALCOHOLISM: -Nicotine decreases Osteoblast activity -It inhibits revascularization of bone grafts -It inhibits expression of wide range of cytokines -Induces Osteoporosis -Reduces estrogen effectiveness -Counter the antioxidant property of Vit.C and E
  • 47.
    10. CHEMICAL ORTHERMAL BURNS: Decreases fracture healing 11. ANAEMIA AND HYPOXIA: Decreases fracture healing 12. DENERVATION AND NEUROPATHIES: Decreases fracture healing
  • 48.
    13. INFECTIONS: Delays healing 14.VENOUS STASIS: Delays healing 15. METAL ALLERGY: Delays healing
  • 49.
    16. EFFECTS OFRADIATION: -Causes long term suppressive effect on Haversian system by reducing vascularity and cellularity. -Post operative Radiations reduces bone graft incorporation and should be delayed for 3 weeks. -It may lead to Osteo-radionecrosis, Fractures, Bone growth changes, Radiation induced Cancers
  • 51.
    SOME FACTS TONOTE  Fracture repair and consolidation are inversely proportional to the amount of mobility at fracture site.  Compression at fracture; -physiological compression stimulate bone formation -compression is useful for spongy bone while its harmful for diaphyseal bones
  • 52.
    METHODS TO ENHANCEFRACTURE HEALING  ELECTRICAL STIMULATION; -Direct current -Inductive coupling -Capacitive coupling  EXTRA CORPOREAL SHOCK WAVE THERAPY  MECHANICAL STIMULATION  BIOLOGICAL METHODS -Bone morphogenic proteins -Prostacyclins -Platelet concentrate and Bone marrow injections -Parathyroid hormone -Ultra concentrate of centrifuged blood -Anabolic supplementations and minerals -Bone grafts and substitutes
  • 53.
    FACTORS INFLUENCING/AFFECTING FRACTURE HEALING These factors can be subdivided into systemic and local factors.  Systemic factors present at the time of injury with exception of trauma to the CNS.  Local factors subdivided according to their nature such as mechanical , chemical ,physical, or environmental. Such classification has little clinical importance.
  • 54.
    SYSTEMIC FACTORS A. Age B.Activity level including--- 1. General immobilization 2. space flight C. Nutritional status D. Hormonal factors 1.GH 2.Corticosteroids(microvascular AVN) 3. others- thyroid, estrogen , androgen, calcitonin, PTH,PG
  • 55.
    E. Diseases:- anemia,neuropathies,tabes F. Vitamin defcncy: A,D,E,K G. Drugs : NSAIDs, anticoagulants ,CCB, sodium fluride, tetracycline. H. Nicotine, alcohol I. Hyperoxia J. Systemic growth factors K. Environmental temperature L. CNS trauma
  • 56.
    LOCAL FACTORS A. Factorsindependent of injury, treatment, or complications 1. Type of bone 2. Abnormal bone -- radiation necrosis --- infection --- tumours and other pathologic conditions. 3. Denervation
  • 57.
    B. Factors dependingon injury 1. Degree of local damage a.compound # b. communition of # c. velocity of injury d. low circulation levels of vit.K
  • 58.
    2. Extent ofdisruption of vascular supply to bone, it,s fragments, soft tissue or severity of injury. 3. Type and location of fracture( one /2 bones ie tibia and fibula or tibia alone. 4. Loss of bone 5. soft tissue interposition 6. Local growth factors.
  • 59.
    C. Factors dependingon treatment___ 1. Extent of surgical trauma( bld supply, heat) 2. Implant induced altered bld flow 3. Degree and kind of rigidity of external/internal fixation and influence of timing. 4. Degree, duration and direction of load- induced deformation of bone and soft tissue 5. Extent of contact b/w fragments 6. Factors stimulating post traumatic osteogenesis ----- bone graft, BMPs, electrical stimulation ,surgical technique ,intermittent venous stasis.
  • 60.
    D. Factors associatedwith complications 1. infection 2. venous stasis 3. metal allergy
  • 61.
    VARIABLES THAT INFLUENCEFRACTURE HEALING  Cruess and Buck Walter have devided the varibles into 4 Groups 1. INJURY VARIABLES 2. PATIENT VARIABLES 3. TISSUE VARIBLES 4. TREATMENT VARIABLES
  • 62.
    1. INJURY VARIABLE A)Open #s---- causes soft tissue destruction and disturbe blood suply prevent haematoma fornation and delayed repair B) Severity of injury----- severe injury lead to extensive soft tissue damage and bone communition with displacement ,leading to retardation of fracture healing. C. Intra-articular #s ---- synovial fluid hinders the fracture healing as it contains collagenases which degrade the matrix of initial # callus. So intra-articular #s require reconstruction of joint, stable fixation of fragments and early mobilisation.
  • 63.
    D) Soft tissueinterposition---- compromise # healing E) Segmental fracture------ of long bone impairs the intramedullary blood suply of middle fragment resulting in delayed union/non union. F) Damage to blood supply---- lead to delay/ prevent # healing.
  • 64.
    PATIENT VARIBLES 1. Age:-infants and childrn have rapid rate of healing where as healing declines significantly with age advances. 2. Nutrition :- poor nutritional status decreases synthesis of large volumes of collagens, polyglycans and other matrix macromolecules, hence affect fracture healing and can lead to mortality. 3. Systemic hormones:-- corticosteroids, NSAIDs , anticoagulants inhibit fracture healing. Where as GH, TH,insulin,and anabolic steroids enhance fracture healing. 4. Nicotine :-- cigarette smoking inhibit # healing by inhibiting vascularisation of cancellous bone graft.
  • 65.
    TISSUE VARIABLES 1. Formof bone ( cancellous/ cortical): cancellous bone healing rapid because of larger surface area per unit volume,and rich blood supply. 2. Bone necrosis :-- leads to decreased bone healing. 3. Bone diseases :- osteoporosis, osteomalacia, primary malignant tumors, osteogenesis imperfecta etc all cause pathological # and delay in healing process. 4. Infection :- slow down / prevents healing. Infection will cause necrosis of normal tissue, edema and thrombosis of blood vessels, threby retarding or prevent healing.
  • 66.
    TREATMENT VARIABLES 1. Appositionof fracture fragments :- Decreasing the # gap decreases volume of repair tissue needed to heal a fracture. Anatomical reduction causes rapid healing as compared to displaced fragments. 2. Loading and micromotion:-- Loading a # site stimulate bone formation while decreased loading slows fracture healing. Immediate controlled loading and limb movement, including induced micromotion at long fracture sites, promotes fracture healing but too much movement cause nonunion. 3. Stabilization of fracture :- will prevent repeated disruption of repair tissue and speed up the fracture callus. 4. Rigid fixation :-- Plate like LC-DCP leads to primary union of fracture, stable fixation allows early mobilization of joints and hence prevents stiffness.
  • 67.
    5. Bone grafting:-- It is osteo inductive as well as osteoconductive. BMP stimulates healing. Autograft and allograft of cancellous , cortical or cortico-cancellous bone are used to stimulate # healing and replace lost bone. 6. Ultrasound:- low intensity pulsed USG accelerate # healing. It increases the concentration of intracellular calcium in fracture callus chondrocytes. 7 . Demineralized mone marrow :--- The factors in bone marrow stimulate bone formation, by migration of undifferentiated mesenchymal cells to the implanted matrix and differentiation into chondrocytes.
  • 68.
    Electrical and electromagneticstimulation The fibrous union can be converted into a fibrocartilage which then undergoes enchondral ossification by using cathode electrodes,each delivering an optimal osteogenic current of 20micro.amp At least 3 electrical and electromagnetic methodes are available. 1. Invasive 2. Semi-invasive 3. Non-invasive
  • 69.
    Invasive method  Aself powered, self contained and totally implantable electrical stimulation is used.  Union is achieved in more than 85% 0s cases within 12-36 weeks.
  • 70.
    Semi-invasive method  Consistsof insertion of cathodes percutaneously into the nonunion site and continous application of small amount of direct current. Early osteogenesis can be detected in 12 weeks.
  • 71.
    Non-invasive method  Weakelectric currents are induced by pulsating elctromagnetic fields.  radiograph made after 4-6 wks interval shows evidence of healing.
  • 72.
    REFERENCES CAMPBELL’S OPERATIVE ORTHOPEDICS ROCKWOODAND GREEN ESSENTIAL ORTHOPEDICS-VARSHNEY
  • 73.

Editor's Notes

  • #18  Gowen M. Cytokines and Bone Metabolism. London: CRC Press, 1992.
  • #22 Einhorn T. Enhancement of fracture healing. AAOS Instructional Course Lectures, 1996. Buckwalter, Einhorn, Simon (ed.) Orthopaedic Basic Science 2nd ed. AAOS, 1999.
  • #26 OKU-6
  • #27 Buckwalter, Einhorn, Simon (ed.) Orthopaedic Basic Science 2nd ed. AAOS, 1999. Favus (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 4th ed. Lippincott Williams and Wilkins, 1999.
  • #28 Favus (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 4th ed. Lippincott Williams and Wilkins, 1999.
  • #29 Buckwalter, Einhorn, Simon (ed.) Orthopaedic Basic Science 2nd ed. AAOS, 1999. Favus (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 4th ed. Lippincott Williams and Wilkins, 1999.
  • #30 Favus (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 4th ed. Lippincott Williams and Wilkins, 1999.
  • #34 Buckwalter, Einhorn, Simon (ed.) Orthopaedic Basic Science 2nd ed. AAOS, 1999.
  • #35 Buckwalter, Einhorn, Simon (ed.) Orthopaedic Basic Science 2nd ed. AAOS, 1999.
  • #36 Buckwalter, Einhorn, Simon (ed.) Orthopaedic Basic Science 2nd ed. AAOS, 1999.
  • #37 Buckwalter, Einhorn, Simon (ed.) Orthopaedic Basic Science 2nd ed. AAOS, 1999.